LEGATO is part of a series of clinical trials funded by the Horizon Europe programme as part of the EU Mission on Cancer. The twelve clinical trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster. In this video, the project’s Principal Investigator and Co-Leader, Prof. Dr Matthias Preusser from the Medical University of Vienna explains the aims and objectives of the LEGATO Project.